News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

bluebird bio to Present at the 31st Annual J.P. Morgan Healthcare Conference


1/3/2013 6:35:37 AM

bluebird bio, a leader in the development of potentially transformative one-time gene therapies for severe genetic diseases, announced today that Nick Leschly, chief bluebird, is scheduled to present at the 31st Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2013 at 9:30 AM PST at the Westin St. Francis Hotel in San Francisco.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES